406 related articles for article (PubMed ID: 8514591)
1. Professional drug labeling.
Terry M
J Am Vet Med Assoc; 1993 May; 202(10):1711-2;discussion 1713-7. PubMed ID: 8514591
[No Abstract] [Full Text] [Related]
2. Scientific basis for nonapproved use of drugs in veterinary practice.
Brumbaugh GW
J Am Vet Med Assoc; 1993 May; 202(10):1693-6;discussion 1713-7. PubMed ID: 8514586
[No Abstract] [Full Text] [Related]
3. Extra-label drug use--veterinary practitioner views: food animals.
Johnson DE
J Am Vet Med Assoc; 1993 May; 202(10):1645-7;discussion 1654-8. PubMed ID: 8514573
[No Abstract] [Full Text] [Related]
4. Drug use guidelines for veterinary practitioners.
Gloyd JS
J Am Vet Med Assoc; 1993 May; 202(10):1738-9;discussion 1740-1. PubMed ID: 8514600
[No Abstract] [Full Text] [Related]
5. Extra-label drug use--veterinary practitioner views: companion animals.
Cleland JL
J Am Vet Med Assoc; 1993 May; 202(10):1642-4;discussion 1654-58. PubMed ID: 8514572
[No Abstract] [Full Text] [Related]
6. Educating veterinarians to prescribe and use drugs in a responsible manner.
Jenkins WL
J Am Vet Med Assoc; 1993 May; 202(10):1708-10;discussion 1713-7. PubMed ID: 8514590
[No Abstract] [Full Text] [Related]
7. Extra-label drug use: the lifeblood of zoo animal and wildlife medicine.
Lance WR
J Am Vet Med Assoc; 1993 May; 202(10):1649-50;discussion 1654-8. PubMed ID: 8514575
[No Abstract] [Full Text] [Related]
8. Implications for the FDA/Center for Veterinary Medicine (CVM).
Geyer RE
J Am Vet Med Assoc; 1993 May; 202(10):1718-23. PubMed ID: 8514592
[No Abstract] [Full Text] [Related]
9. AVMA legislation: partial solution to drug availability problem.
Gloyd JS
J Am Vet Med Assoc; 1993 Apr; 202(7):1055-6. PubMed ID: 8473213
[No Abstract] [Full Text] [Related]
10. Practitioners face conundrum with off-lable pesticide use. COBTA recommends regulatory discretion; prohibition remains.
J Am Vet Med Assoc; 2004 Jul; 225(2):190-1. PubMed ID: 15323370
[No Abstract] [Full Text] [Related]
11. Extra-label rules: the final outcome.
Curry-Galvin E
J Am Vet Med Assoc; 1997 Jan; 210(1):10-2. PubMed ID: 8977639
[No Abstract] [Full Text] [Related]
12. Current FDA policy on use of human-labeled drugs in animals.
Teske RH
J Am Vet Med Assoc; 1993 May; 202(10):1632-3;discussion 1634. PubMed ID: 8514570
[No Abstract] [Full Text] [Related]
13. Flexible labeling, streamlined drug approval advocated at workshop.
Raef TA
J Am Vet Med Assoc; 1995 Jul; 207(1):7-9. PubMed ID: 7601697
[No Abstract] [Full Text] [Related]
14. Compounding forum: FDA-CVM hears veterinarians' views.
J Am Vet Med Assoc; 1993 Nov; 203(10):1367-72. PubMed ID: 8276690
[No Abstract] [Full Text] [Related]
15. An overview of current programs on drug development and regulation for small ruminants--pharmaceutical industry perspective.
Terry M
Vet Hum Toxicol; 1993; 35 Suppl 2():12-3. PubMed ID: 8236759
[No Abstract] [Full Text] [Related]
16. Proper drug use in practice.
Mod Vet Pract; 1977 Sep; 58(9):743-8. PubMed ID: 562465
[No Abstract] [Full Text] [Related]
17. Adverse drug reactions.
Stowe CM
J Am Vet Med Assoc; 1975 May; 166(10):980-1. PubMed ID: 1126860
[No Abstract] [Full Text] [Related]
18. Responsibilities under an amended Food, Drug & Cosmetic Act: companion animal practitioners.
Kay WJ
J Am Vet Med Assoc; 1993 May; 202(10):1736-7;discussion 1740-1. PubMed ID: 8514599
[No Abstract] [Full Text] [Related]
19. FDA perspectives on supplement use by patients on antithrombotic therapy.
Kim MJ
Thromb Res; 2005; 117(1-2):197-200; discussion 201-7. PubMed ID: 16188297
[No Abstract] [Full Text] [Related]
20. Clinical trials from the industry viewpoint.
McKinley RE
J Am Vet Med Assoc; 1972 Dec; 161(11):1391-4. PubMed ID: 4638519
[No Abstract] [Full Text] [Related]
[Next] [New Search]
